FOXC1 and chronic obstructive pulmonary disease: Forkhead box C1 (FOXC1) is reported to attenuate the inflammation in chronic obstructive pulmonary disease (Xia et al., 2019), and homeobox 10 (HOXA10) is demonstrated to contribute to the innate immune response and suppress inflammation (Wang et al., 2015).